| Title : Alzheimer's Disease and Its Potential Alternative Therapeutics - Kisby_2019_J.Alzheimers.Dis.Parkinsonism_9_ |
| Author(s) : Kisby B , Jarrell JT , Agar ME , Cohen DS , Rosin ER , Cahill CM , Rogers JT , Huang X |
| Ref : J Alzheimers Dis Parkinsonism , 9 : , 2019 |
| Abstract : |
| PubMedSearch : Kisby_2019_J.Alzheimers.Dis.Parkinsonism_9_ |
| PubMedID: 31588368 |
| Title : Synthesis of the Alzheimer Drug Posiphen into its Primary Metabolic Products (+)-N1-norPosiphen, (+)-N8-norPosiphen and (+)-N1, N8-bisnorPosiphen, their Inhibition of Amyloid Precursor Protein, alpha -Synuclein Synthesis, Interleukin-1beta Release, and Cholinergic Action - Yu_2013_Antiinflamm.Antiallergy.Agents.Med.Chem_12_117 |
| Author(s) : Yu QS , Reale M , Kamal MA , Holloway HW , Luo W , Sambamurti K , Ray B , Lahiri DK , Rogers JT , Greig NH |
| Ref : Antiinflamm Antiallergy Agents Med Chem , 12 :117 , 2013 |
| Abstract : |
| PubMedSearch : Yu_2013_Antiinflamm.Antiallergy.Agents.Med.Chem_12_117 |
| PubMedID: 23360256 |
| Title : The anticholinesterase phenserine and its enantiomer posiphen as 5'untranslated-region-directed translation blockers of the Parkinson's alpha synuclein expression - Mikkilineni_2012_Parkinsons.Dis_2012_142372 |
| Author(s) : Mikkilineni S , Cantuti-Castelvetri I , Cahill CM , Balliedier A , Greig NH , Rogers JT |
| Ref : Parkinsons Dis , 2012 :142372 , 2012 |
| Abstract : |
| PubMedSearch : Mikkilineni_2012_Parkinsons.Dis_2012_142372 |
| PubMedID: 22693681 |
| Title : Rationale for the development of cholinesterase inhibitors as anti-Alzheimer agents - Lahiri_2004_Curr.Pharm.Des_10_3111 |
| Author(s) : Lahiri DK , Rogers JT , Greig NH , Sambamurti K |
| Ref : Curr Pharm Des , 10 :3111 , 2004 |
| Abstract : |
| PubMedSearch : Lahiri_2004_Curr.Pharm.Des_10_3111 |
| PubMedID: 15544501 |